{"id":"https://openalex.org/W2010358693","doi":"https://doi.org/10.1182/blood-2011-06-362434","title":"Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents","display_name":"Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents","publication_year":2011,"publication_date":"2011-12-09","ids":{"openalex":"https://openalex.org/W2010358693","doi":"https://doi.org/10.1182/blood-2011-06-362434","mag":"2010358693","pmid":"https://pubmed.ncbi.nlm.nih.gov/22160379","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3271713"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2011-06-362434","doi":"https://doi.org/10.1182/blood-2011-06-362434","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2011-06-362434","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010358693"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3271713","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084226328","display_name":"Sajal K. Ghosh","orcid":"https://orcid.org/0000-0002-1187-6994","observed_orcids":["https://orcid.org/0000-0002-1187-6994"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sajal K. Ghosh","raw_affiliation_strings":["Cancer Center, Boston University School of Medicine, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Boston University School of Medicine, Boston, MA; and","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086539163","display_name":"Susan P. Perrine","orcid":"https://orcid.org/0000-0003-2179-8376","observed_orcids":["https://orcid.org/0000-0003-2179-8376"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan P. Perrine","raw_affiliation_strings":["Cancer Center, Boston University School of Medicine, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Boston University School of Medicine, Boston, MA; and","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002113213","display_name":"Robert M. Williams","orcid":"https://orcid.org/0000-0001-9063-1284","observed_orcids":["https://orcid.org/0000-0001-9063-1284"]},"institutions":[{"id":"https://openalex.org/I92446798","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17","country_code":"US","type":"education","lineage":["https://openalex.org/I92446798"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Williams","raw_affiliation_strings":["Department of Chemistry, Colorado State University, Fort Collins, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Colorado State University, Fort Collins, CO","institution_ids":["https://openalex.org/I92446798"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083735394","display_name":"Douglas V. Faller","orcid":"https://orcid.org/0000-0002-2454-3478","observed_orcids":["https://orcid.org/0000-0002-2454-3478"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas V. Faller","raw_affiliation_strings":["Cancer Center, Boston University School of Medicine, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Boston University School of Medicine, Boston, MA; and","institution_ids":["https://openalex.org/I111088046"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.7281,"has_fulltext":false,"cited_by_count":167,"citation_normalized_percentile":{"value":0.93783239,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"119","issue":"4","first_page":"1008","last_page":"1017"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.3617999851703644,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.013199999928474426,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.972000002861023},{"id":"https://openalex.org/keywords/viral-latency","display_name":"viral latency","score":0.6970000267028809},{"id":"https://openalex.org/keywords/ebv-associated-lymphoma","display_name":"EBV-associated lymphoma","score":0.8669999837875366},{"id":"https://openalex.org/keywords/ganciclovir","display_name":"ganciclovir","score":0.9330000281333923},{"id":"https://openalex.org/keywords/sodium-butyrate","display_name":"sodium butyrate","score":0.796999990940094},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hydroxamic-acids","display_name":"hydroxamic acids","score":0.843999981880188},{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.8759999871253967},{"id":"https://openalex.org/keywords/belinostat","display_name":"belinostat","score":0.9819999933242798},{"id":"https://openalex.org/keywords/entinostat","display_name":"entinostat","score":0.8709999918937683},{"id":"https://openalex.org/keywords/apicidin","display_name":"apicidin","score":0.8629999756813049},{"id":"https://openalex.org/keywords/largazole","display_name":"largazole","score":0.9860000014305115},{"id":"https://openalex.org/keywords/scriptaid","display_name":"Scriptaid","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.6709614396095276},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.627304196357727},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.6247079372406006},{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.5619309544563293},{"id":"https://openalex.org/C2778942008","wikidata":"https://www.wikidata.org/wiki/Q305004","display_name":"Sodium butyrate","level":3,"score":0.5562957525253296},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.461882084608078},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45553329586982727},{"id":"https://openalex.org/C168831097","wikidata":"https://www.wikidata.org/wiki/Q413248","display_name":"Depsipeptide","level":2,"score":0.4406631886959076},{"id":"https://openalex.org/C182615771","wikidata":"https://www.wikidata.org/wiki/Q1369386","display_name":"Lytic cycle","level":3,"score":0.42851221561431885},{"id":"https://openalex.org/C2776281265","wikidata":"https://www.wikidata.org/wiki/Q420327","display_name":"Hydroxamic acid","level":2,"score":0.42153066396713257},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3735243082046509},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3654058277606964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3507084250450134},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2743910551071167},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.23554840683937073},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17140033841133118},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.16004270315170288},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07004469633102417},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D009994","descriptor_name":"Osmolar Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014775","descriptor_name":"Virus Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015774","descriptor_name":"Ganciclovir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015967","descriptor_name":"Gene Expression Regulation, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood-2011-06-362434","doi":"https://doi.org/10.1182/blood-2011-06-362434","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2011-06-362434","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3271713","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3271713","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},{"id":"pmid:22160379","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22160379","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3271713","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3271713","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3733795147","display_name":null,"funder_award_id":"CA153474","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4055380541","display_name":"Virus-Targeted Therapy for Malignancies","funder_award_id":"R43CA153474","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7929356652","display_name":"Multiple Myeloma and Cancer Therapies via Largazole Analogs","funder_award_id":"R01CA152314","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306536","display_name":"V Foundation for Cancer Research","ror":"https://ror.org/00kbbk236"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W33386600","https://openalex.org/W1493515748","https://openalex.org/W1512604580","https://openalex.org/W1556928407","https://openalex.org/W1567714677","https://openalex.org/W1763097249","https://openalex.org/W1889279766","https://openalex.org/W1968496091","https://openalex.org/W1970884060","https://openalex.org/W1983094204","https://openalex.org/W1983315005","https://openalex.org/W1985124754","https://openalex.org/W1993273200","https://openalex.org/W2013919679","https://openalex.org/W2020639373","https://openalex.org/W2026387044","https://openalex.org/W2031162215","https://openalex.org/W2044179374","https://openalex.org/W2047090205","https://openalex.org/W2051257692","https://openalex.org/W2063819389","https://openalex.org/W2067238682","https://openalex.org/W2070420459","https://openalex.org/W2081973434","https://openalex.org/W2082823816","https://openalex.org/W2083784041","https://openalex.org/W2088231330","https://openalex.org/W2090254744","https://openalex.org/W2095572685","https://openalex.org/W2096520038","https://openalex.org/W2099077578","https://openalex.org/W2102015088","https://openalex.org/W2106679588","https://openalex.org/W2109987329","https://openalex.org/W2113977976","https://openalex.org/W2114130971","https://openalex.org/W2114894149","https://openalex.org/W2118650392","https://openalex.org/W2125514026","https://openalex.org/W2127791051","https://openalex.org/W2133653334","https://openalex.org/W2145455317","https://openalex.org/W2149379768","https://openalex.org/W2158178080","https://openalex.org/W2161947099","https://openalex.org/W2163247444","https://openalex.org/W2163446263","https://openalex.org/W2402730709","https://openalex.org/W2979799584"],"related_works":["https://openalex.org/W2979436579","https://openalex.org/W1593352795","https://openalex.org/W2007970538","https://openalex.org/W2120257761","https://openalex.org/W2187924450","https://openalex.org/W2268851705","https://openalex.org/W1538432746","https://openalex.org/W4394909932","https://openalex.org/W2102015088","https://openalex.org/W2090683194"],"abstract_inverted_index":{"Induction":[0],"of":[1,57,78,87,149,157,192,207],"EBV":[2,34,79],"lytic-phase":[3,35],"gene":[4,36],"expression,":[5],"combined":[6],"with":[7,61],"exposure":[8],"to":[9,20,32,83,97,103,167,181,202],"an":[10],"antiherpes":[11,71],"viral":[12,72],"drug,":[13],"represents":[14],"a":[15,58],"promising":[16],"targeted":[17],"therapeutic":[18],"approach":[19],"EBV-associated":[21,208],"lymphomas.":[22,209],"Short-chain":[23],"fatty":[24,112],"acids":[25,113,120],"or":[26],"certain":[27],"chemotherapeutics":[28],"have":[29,48],"been":[30],"used":[31],"induce":[33],"expression":[37],"in":[38,75,106],"cultured":[39],"cells":[40,102,166],"and":[41,69,116,129,139,154,171,178,190],"mouse":[42],"models,":[43],"but":[44],"these":[45,193],"studies":[46],"generally":[47],"not":[49],"translated":[50],"into":[51],"clinical":[52,59],"application.":[53],"The":[54,188],"recent":[55],"success":[56],"trial":[60],"the":[62,70,76,85,132,135,140,147,158,205],"pan-histone":[63],"deacetylase":[64],"(pan-HDAC)":[65],"inhibitor":[66,144],"arginine":[67],"butyrate":[68,115],"drug":[73],"ganciclovir":[74],"treatment":[77,206],"lymphomas":[80],"prompted":[81],"us":[82],"investigate":[84],"potential":[86],"several":[88],"HDAC":[89,143,160,194],"inhibitors,":[90],"including":[91],"some":[92],"new,":[93],"highly":[94],"potent":[95,185],"compounds,":[96],"sensitize":[98],"EBV(+)":[99,164],"human":[100],"lymphoma":[101,165],"antiviral":[104],"agents":[105],"vitro.":[107],"Our":[108],"study":[109],"included":[110],"short-chain":[111],"(sodium":[114],"valproic":[117],"acid);":[118],"hydroxamic":[119,125,152],"(oxamflatin,":[121],"Scriptaid,":[122],"suberoyl":[123,150],"anilide":[124,151],"acid,":[126],"panobinostat":[127],"[LBH589],":[128],"belinostat":[130],"[PXD101]);":[131],"benzamide":[133],"MS275;":[134],"cyclic":[136],"tetrapeptide":[137],"apicidin;":[138],"recently":[141],"discovered":[142],"largazole.":[145],"With":[146],"exception":[148],"acid":[153],"PXD101,":[155],"all":[156],"other":[159],"inhibitors":[161,195],"effectively":[162],"sensitized":[163],"ganciclovir.":[168],"LBH589,":[169],"MS275,":[170],"largazole":[172],"were":[173,179],"effective":[174],"at":[175],"nanomolar":[176],"concentrations":[177],"10(4)":[180],"10(5)":[182],"times":[183],"more":[184],"than":[186],"butyrate.":[187],"effectiveness":[189],"potency":[191],"make":[196],"them":[197],"potentially":[198],"applicable":[199],"as":[200],"sensitizers":[201],"antivirals":[203],"for":[204]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
